A large Danish cohort study showed no significant increase in neurodevelopmental disorders (NDDs) among children fathered by men taking valproate during spermatogenesis, challenging earlier safety concerns and current UK restrictions on valproate use in men. As previously reported by Medscape Medical News, the decision to restrict the drug in women and in men younger than …
Leave a Comment Leave a Comment
